{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:02:10Z","timestamp":1771610530797,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jns.2018.09.035","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T02:58:21Z","timestamp":1538621901000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus"],"prefix":"10.1016","volume":"396","author":[{"given":"Shin-ichiro","family":"Hamano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuo","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.09.035_bb0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00000542-197905000-00017","article-title":"Clinical, electroencephalographic and pharmacokinetic studies of a water-soluble benzodiazepine, midazolam maleate","volume":"50","author":"Brown","year":"1979","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jns.2018.09.035_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/emj.4.3.169","article-title":"Midazolam: an effective intravenous agent for seizure control","volume":"4","author":"Galvin","year":"1987","journal-title":"Arch. Emerg. Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/08830738020170123002","article-title":"Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome","volume":"17","author":"Koul","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s100720200058","article-title":"Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus","volume":"23","author":"Ulvi","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2018.09.035_bb0025","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","article-title":"High-dose midazolam therapy for refractory status epilepticus in children","volume":"32","author":"Morrison","year":"2006","journal-title":"Intensive Care Med."},{"issue":"Suppl. 7","key":"10.1016\/j.jns.2018.09.035_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/epi.12307","article-title":"Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League against Epilepsy","volume":"54","author":"Capovilla","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2018.09.035_bb0035","series-title":"Pharmacological Update of Clinical Guideline 20","article-title":"The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care","author":"Royal College of Physicians (UK)","year":"2012"},{"key":"10.1016\/j.jns.2018.09.035_bb0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11940-011-0148-3","article-title":"Treatment of pediatric status epilepticus","volume":"13","author":"Loddenkemper","year":"2011","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11910-010-0170-y","article-title":"Treatment of refractory status epilepticus in childhood","volume":"11","author":"Schreiber","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jns.2018.09.035_bb0050","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"Task force on status epilepticus of the ILAE Commission for European Affairs. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2018.09.035_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-510X(03)00036-4","article-title":"Treatment of status epilepticus: a survey of neurologists","volume":"211","author":"Claassen","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.09.035_bb0060","first-page":"290","article-title":"Efficacy of continuous intravenous infusion of midazolam in the treatment of status epilepticus in children","volume":"30","author":"Minagawa","year":"1998","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.jns.2018.09.035_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0387-7604(00)00116-9","article-title":"Midazolam as a first-line agent for status epilepticus in children","volume":"22","author":"Yoshikawa","year":"2000","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2018.09.035_bb0070","first-page":"484","article-title":"Eight-year study on the treatment with intravenous midazolam for status epilepticus and clusters of seizures in children","volume":"35","author":"Minagawa","year":"2003","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.jns.2018.09.035_bb0075","first-page":"304","article-title":"Midazolam treatment in status epilepticus of children","volume":"35","author":"Hamano","year":"2003","journal-title":"No to Hattasu"},{"key":"10.1016\/j.jns.2018.09.035_bb0080","first-page":"395","article-title":"Choice and administration sequence of antiepileptic agents for status epilepticus and frequent seizures in children","volume":"37","author":"Hamano","year":"2005","journal-title":"No to Hattasu"},{"key":"10.1016\/j.jns.2018.09.035_bb0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pediatrneurol.2007.02.012","article-title":"Efficacy of intravenous midazolam for status epilepticus in childhood","volume":"36","author":"Hayashi","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0090","first-page":"185","article-title":"Treatment of status epilepticus","volume":"39","author":"Osawa","year":"2007","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.jns.2018.09.035_bb0095","series-title":"Status Epilepticus: Mechanisms and Management","first-page":"515","article-title":"Management of status epilepticus in infants and children","author":"Evrard","year":"2006"},{"key":"10.1016\/j.jns.2018.09.035_bb0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"22","author":"Bancaud","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2018.09.035_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","article-title":"It\u2019s time to revise the definition of status epilepticus","volume":"40","author":"Lowenstein","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2018.09.035_bb0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: ontogeny and drug disposition","volume":"37","author":"de Wildt","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jns.2018.09.035_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3805\/jjes.23.114","article-title":"Efficacy of intravenous treatment of midazolam in children with status epilepticus","volume":"23","author":"Sakaue","year":"2005","journal-title":"J. Jpn. Epilepsy Soc."},{"key":"10.1016\/j.jns.2018.09.035_bb0120","series-title":"FY 2004 Summary and Shared Research Report","first-page":"29","article-title":"Efficacy of intravenous midazolam therapy in children with status epilepticus. The Ministry of Health, Labour and Welfare Grant-in-Aid for Scientific Research (Clinical research project for pediatric diseases)","author":"Yoshikawa","year":"2005"},{"key":"10.1016\/j.jns.2018.09.035_bb0125","first-page":"77","article-title":"Usefulness of midazolam for status epilepticus during childhood: differences in cause of seizure and clinical manifestations","volume":"21","author":"Hamano","year":"2005","journal-title":"J. Saitama Child. Med. Cent."},{"key":"10.1016\/j.jns.2018.09.035_bb0130","series-title":"FY 2003 Summary and Shared Research Report","first-page":"42","author":"Osawa","year":"2004"},{"key":"10.1016\/j.jns.2018.09.035_bb0135","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PCC.0000000000000173","article-title":"Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies","volume":"15","author":"Wilkes","year":"2014","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus","volume":"17","author":"Singhi","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.yebeh.2009.02.018","article-title":"Intravenous midazolam in convulsive status epilepticus in children with pharmacoresistant epilepsy","volume":"14","author":"Papavasiliou","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2018.09.035_bb0150","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/PCC.0000000000000900","article-title":"Refractory status epilepticus in children: intention to treat with continuous infusions of midazolam and pentobarbital","volume":"17","author":"Tasker","year":"2016","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0155","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/0883073816638757","article-title":"A comparison of midazolam, lorazepam, and diazepam for the treatment of status epilepticus in children: a network meta-analysis","volume":"31","author":"Zhao","year":"2016","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0160","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","article-title":"High-dose midazolam therapy for refractory status epilepticus in children","volume":"32","author":"Morrison","year":"2006","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/08830738050200060201","article-title":"Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin","volume":"20","author":"Brevoord","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0170","first-page":"287","article-title":"Comparison of intravenous lidocaine and midazolam infusion for refractory convulsive status epilepticus in children","volume":"4","author":"Fallah","year":"2007","journal-title":"J. Pediatr. Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003088-199835010-00003","article-title":"Clinical pharmacology of midazolam in infants and children","volume":"35","author":"Blumer","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jns.2018.09.035_bb0180","first-page":"301","article-title":"Clinical pharmacokinetics of midazolam in the treatment of status epilepticus in children","volume":"38","author":"Minagawa","year":"2006","journal-title":"No to Hattatsu"},{"key":"10.1016\/j.jns.2018.09.035_bb0185","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1212\/WNL.54.6.1366","article-title":"Prolongation of midazolam half-life after sustained infusion for status epilepticus","volume":"54","author":"Naritoku","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.09.035_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus","volume":"82","author":"Fernandez","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.09.035_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.jns.2018.09.035_bb0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pediatrneurol.2014.02.021","article-title":"Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus","volume":"51","author":"Nagase","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2018.09.035_bb0205","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00003246-199204000-00009","article-title":"Intravenous midazolam for the treatment of refractory status epilepticus","volume":"20","author":"Kumar","year":"1992","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/00003246-199307000-00011","article-title":"Midazolam in the treatment of status epilepticus in children","volume":"21","author":"Rivera","year":"1993","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0215","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.44.10.1837","article-title":"Treatment of refractory generalized status epilepticus with continuous infusion of midazolam","volume":"44","author":"Parent","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.09.035_bb0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/adc.76.5.445","article-title":"Continuous midazolam infusion as treatment of status epilepticus","volume":"76","author":"Koul","year":"1997","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jns.2018.09.035_bb0225","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/00003246-199909000-00043","article-title":"Midazolam coma for refractory status epilepticus in children","volume":"27","author":"Igartua","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jns.2018.09.035_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.seizure.2004.12.005","article-title":"Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus","volume":"14","author":"Ozdemir","year":"2005","journal-title":"Seizure"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T12:49:13Z","timestamp":1566478153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18304106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":46,"alternative-id":["S0022510X18304106"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.09.035","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}